Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis India Ltd.

http://www.novartis.in

Latest From Novartis India Ltd.

Pfizer Latest Foreign Firm To Axe India Field Force Jobs: Here’s The Big Picture Take

Pfizer effects hundreds of field force job cuts in India as it rewires its commercialization approach and creates new roles leveraging its ‘digital core’, but industry experts suggest there is a complex mix of other factors at play as well.

India Commercial

India Physician Conduct Rules Want Them Off Pharma-Sponsored Symposia

Wider-ranging new draft rules suggest that physicians in India should not engage in educational activity sponsored by pharma and urges them to declare financial earnings and benefits received from industry via an affidavit. The Pink Sheet discusses with industry experts some of the nuances and seeming loopholes in the rules, currently in self-regulatory mode but with penalties proposed for violation.

India Regulation

Mark Cuban’s US Pharma Ventures: Ally Or Gadfly In The Mix For Indian Firms?

Mark Cuban’s newly launched online pharmacy and pharmacy benefit manager operation in the US has sparked interest in India. Can the billionaire entrepreneur’s venture punch above its weight and should Indian firms be watchful?

Asia Pacific India

Mark Cuban’s US Pharma Ventures: Ally Or Gadfly In The Mix For Indian Firms?

Mark Cuban’s newly launched online pharmacy and pharmacy benefit manager operation in the US spark interest in India. Can the billionaire entrepreneur’s venture punch above its weight and should Indian firms be watchful?

Commercial Business Strategies
See All

Company Information

UsernamePublicRestriction

Register